Prkar1a gene knockout in the pancreas leads to neuroendocrine tumorigenesis
In conclusion, this mouse model supports the role of prkar1a as a tumor suppressor gene in the pancreas and points to the PKA pathway as a possible therapeutic target for these lesions.
Source: Endocrine-Related Cancer - Category: Endocrinology Authors: Saloustros, E., Salpea, P., Starost, M., Liu, S., Faucz, F. R., London, E., Szarek, E., Song, W.-J., Hussain, M., Stratakis, C. A. Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Endocrinology | Gastroenterology | Genetics | Insulin | Neurology | Pancreas | Pancreatic Cancer | Rare Diseases